Sourcing materials and services for the pharmaceutical industry. With bases around the world there is no limit to our capabilities.

About Us

We are Summit Pharmaceuticals Europe. We specialize in the sourcing and supply of raw materials, key intermediates, active ingredients (APIs) and formulations to the pharmaceutical industry.

We are part of Sumitomo Corporation, a leading Japanese integrated trading company. Operating in Europe since over 20 years, we are strategically placed through two offices based in Milan and Madrid. We work closely with our Group Companies around the world to ensure to provide a global network to our customers.

With extensive experience in custom manufacturing, compound licensing opportunities and research alliance, the specialists in Summit Pharmaceuticals Europe can meet the needs of all customers in the pharmaceutical field.

Using our local expertise accumulated over many year, together with our global network of other divisions and Sumitomo Corporation, experts can select competitive and reliable suppliers, monitor their performance and progress, ensuring on-time supply.

Read More

Latest News

SPE team is joining 2022 CPHI in Frankfurt on November 1-3.

SPE Team is joining 2022 CPHI in Frankfurt on November 1-3, please visit us at booth 120C70! For further info please contact: Event details:

SPE team is joining Chemspec Europe

SPE team is joining Chemspec Europe in Frankfurt in May 31st and June 1st. For further info please contact: Event details:

SPE joins BOS Basel

SPE team will join BOS Basel on 08th – 09th June 2022: For further info please contact:

Transfer of Cosmetic business to SACI-CFPA

We are glad to announce the transfer of the Cosmetic business of Summit Pharmaceuticals Europe S.r.l Niederlassung Deutschland, by way of an asset deal, and with effective date 01/04/2022 from Summit Pharmaceuticals Europe S.r.l. (“SPE”) Fully directly owned by Summit Pharmaceuticals International (“SPI”) and fully indirectly owned by Sumitomo Corporation (“SC”) to SACI-CFPA, SAS. fully […]

SPE joins DCAT 2022

SPE team is excited to join DCAT in New York from 21st to 24th march 2022 at our suite at Fifty Hotel Suites Affinia. For further info please contact:

Partnership with Brenta S.r.l.

Summit Pharmaceuticals Europe S.r.l. started a partnership with Brenta S.r.l. ( an innovative start-up specialized in developing nanotechnology platform applications with a special focus on pharmaceutical and material science. It is engaged in nanotechnology and theranostic applications to find solutions to enhance the performance of active pharmaceutical ingredients with critical attributes according to the biopharmaceutical […]

Covid-19 Update

01/12/2020 As the C-19 outbreak continues to spread, SPE Group companies are working from home. If you send us anything by post, courier or fax, in the current circumstances, we cannot give assurance that this will be received or dealt with. Also note that call forwarding on our desk phones may not work, too. For […]

Joint Merger Plan publication.

On June 3rd S.P.E. established a new European legal entity in Milano named Summit Pharmaceuticals Europe S.r.l. We are glad to inform that a cross-border merger of old Summit Pharmaceuticals Europe Limited (in UK) into new Summit Pharmaceuticals Europe S.r.l. (in Italy) is currently on going and is expected to become effective on 30th November […]

PLASTIBASE Hydrocarbon Gel

Summit Pharmaceuticals Europe closed  a partnership with the Canadian company CPL for the promotion of their PLASTIBASE Hydrocarbon Gel. PLASTIBASE is a homogenous, soft, colourless, stainless, odourless and non-irritating ointment base that possesses pharmaceutical product characteristics superior to white petrolatum (USP): -More stable viscosity over a wide temperature range -Superior release of active ingredients -Better […]

Read More